Año: 2022
Journal Impact Factor (JIF): 4,8
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
PHARMACOLOGY & PHARMACY | SCIE | 65/278 | Q1 | T1 | D3 |
INFECTIOUS DISEASES | SCIE | 35/96 | Q2 | T2 | D4 |
Año: 2022
Journal Citation Indicator (JCI): 0,980
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
INFECTIOUS DISEASES | 34/129 | Q2 | T1 | D3 | 74,03 |
PHARMACOLOGY & PHARMACY | 91/366 | Q1 | T1 | D3 | 75,27 |
Año:
2022
CiteScore:
5,500
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology, Toxicology and Pharmaceutics (all) | 10/79 | Q1 | T1 | D2 |
Pharmacology (medical) | 79/260 | Q2 | T1 | D4 |
Infectious Diseases | 109/304 | Q2 | T2 | D4 |
Biochemistry | 205/428 | Q2 | T2 | D5 |
Microbiology | 79/163 | Q2 | T2 | D5 |
Microbiology (medical) | 50/124 | Q2 | T2 | D5 |
SJR año:
2022
Factor de Impacto:
0,792
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 13/110 | Q1 | T1 | D2 |
Pharmacology (medical) | 81/271 | Q2 | T1 | D3 |
Biochemistry | 164/445 | Q2 | T2 | D4 |
Infectious Diseases | 123/324 | Q2 | T2 | D4 |
Microbiology | 64/164 | Q2 | T2 | D4 |
Microbiology (medical) | 51/128 | Q2 | T2 | D4 |
Agencia | Código de Proyecto |
---|---|
Parc Tauli~Research and Innovation Institute (I3PT) Grants Programme/Generalitat de Catalunya | CIR2017/053; CIR2018/039.CERCA |
# | Autor | Afiliación |
---|---|---|
1 | Badia-Cebada, L | Parc Taulí Hospital Universitari (Spain) |
2 | Carmezim, J | Bellvitge Institute for Biomedical Research (Spain) |
3 | Pérez-Rodríguez, MT | Hosp Alvaro Cunqueiro (Spain) |
4 | Bereciartua, E | Hospital Universitario Cruces (Spain) |
5 | López, LE | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Instituto de Salud Carlos III; University of Seville Faculty of Medicine (Spain) |
6 | Montenegro, MR | Hosp Alvaro Cunqueiro (Spain) |
7 | Pomar, V | Hospital of Santa Creu i Sant Pau (Spain) |
8 | Andrés, M | Hosp Consorci Terrassa (Spain) |
9 | Petkova, E | Hosp Univ Fdn Jimenez Diaz (Spain) |
10 | Sopena, N | Infect Dis Dept Hosp Germans Trias & Pujol (Spain) |
11 | Lora-Tamayo, J | Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre (Spain) |
12 | Monsálvez, V | Parc Taulí Hospital Universitari (Spain) |
13 | Ramirez-Hidalgo, MF | Arnau de Vilanova Univ Hosp (Spain) |
14 | Gómez-Zorrilla, S | Instituto de Salud Carlos III; Pompeu Fabra University (Spain) |
15 | Boix, L | Hospital Universitario Mútua Terrassa; Universitat Internacional de Catalunya (UIC) (Spain) |
16 | Meije, Y | Hosp Barcelona (Spain) |
17 | Jiménez, E | Bellvitge University Hospital (Spain) |
18 | Parc Taulí Hospital Universitari (Spain) |